Neurophet (380550.KQ) — Stock Score Summary

Neurophet (380550.KQ) has a MoatMap StockRank of 5/100 based on Quality (29/100), Value (32/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL.

NEUROPHET, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases.

Key Financial Metrics

Price$8.16
Market Cap$99M
Price/Book7.36
Return on Equity-115.1%
Return on Invested Capital-107.6%
Debt/Equity2.76
Gross Margin100.2%
Operating Margin-1208.1%
Revenue Growth-9.9%
Free Cash Flow$-7K

Neurophet operates in the Health Information Services industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Neurophet’s (380550.KQ) StockRank?
MoatMap’s StockRank for Neurophet (380550.KQ) is 5/100, with a Strong Sell signal. It is a composite of Quality (29), Value (32), and Momentum (20) factor ranks across MoatMap’s 19,000+ stock universe.
Does Neurophet have an economic moat?
Neurophet (380550.KQ) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Neurophet a buy, hold, or sell?
MoatMap’s current signal for Neurophet (380550.KQ) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Neurophet in?
Neurophet (380550.KQ) operates in the Healthcare sector, specifically the Health Information Services industry (South Korea).
Browse all ranked stocks380550.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock